Lucid Diagnostics (LUCD) Invested Capital (2021)
Lucid Diagnostics' (LUCD) quarterly Invested Capital came in at $22.4 million in Q3 2021.
Lucid Diagnostics (LUCD) Invested Capital (2021) Analysis & Trends
Lucid Diagnostics (LUCD) has 1 years of Invested Capital data on file, last reported at $22.4 million in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | 3.01 Bn |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | 750.00 Mn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 1.79 Bn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 1.71 Bn |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | 2.00 Mn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 1.34 Bn |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | 243.40 Mn |
| 10 | Lucid Diagnostics | 176.73 Mn | 143.33 Mn | 55,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 22.40 Mn |